ReviewGenes & diseases2026
Trained immunity: New insights into pathogenesis and therapeutic targets in diabetes and diabetic complications.
Review in Genes & diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus, a chronic metabolic condition, is marked by ongoing hyperglycemia and poses an increasing global health issue. Beyond its recognized contribution to the development of cardiovascular diseases and kidney problems, diabetes can profoundly impact immune system functions. Recent developments in immunology have revealed trained immunity as a mechanism through which innate immune cells experience enduring functional modifications following their first encounter with specific stimuli. This review compiles the latest evidence concerning the role of trained immunity in the development of diabetes and its complications. Moreover, it discusses emerging therapeutic opportunities that may arise from modulating trained immunity pathways. This review emphasizes the complex relationship between metabolic dysregulation and innate immune memory by synthesizing results from various studies. It proposes that focusing on trained immunity may provide innovative approaches for managing diabetes and its related complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.